Page last updated: 2024-12-06
ck 0569 a
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
guanidino propyl piperazine: anti-plaque agent; RN given refers to dimethanesulfonate; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 50288 |
| MeSH ID | M0087236 |
Synonyms (26)
| Synonym |
|---|
| ipexidine mesylate |
| D04602 |
| 69017-90-9 |
| ipexidine mesylate (usan) |
| urea, n,n'-(1,4-piperazinediylbis(3,1-propanediyliminocarbonimidoyl)bis(n'-hexyl-, dimethanesulfonate |
| urea, n,n''-(1,4-piperazinediylbis(3,1-propanediyliminocarbonimidoyl)bis(n'-hexyl-, dimethanesulfonate |
| ci8ct0864p , |
| cko 569a |
| 1,4-bis(3-(n-hexylcarbamylguanidino)propyl)piperazine dimethanesulfonic acid |
| ck 0569 a |
| ck-0569 [as the base] |
| 1,1'-(1,4-piperazinediylbis(trimethyleneiminoimidocarbonyl))bis(3-hexylurea) dimethanesulfonate |
| ipexidine mesylate [usan:inn] |
| unii-ci8ct0864p |
| guanidino propyl piperazine |
| ipexidine mesilate |
| ck-0569a |
| ck-569a |
| urea, n,n''-(1,4-piperazinediylbis(3,1-propanediyliminocarbonimidoyl)bis(n'-hexyl-, dimethanesulphonate |
| ck-0569 mesylate |
| ipexidine mesylate [usan] |
| 1,1'-(1,4-piperazinediylbis(trimethyleneiminoimidocarbonyl))bis(3-hexylurea) dimethanesulphonate |
| methanesulfonic acid--n,n''-{piperazine-1,4-diylbis[(propane-3,1-diyl)carbamimidoyl]}bis(n'-hexylcarbamimidic acid) (2/1) |
| DTXSID80988771 |
| Q27275478 |
| 1-[n'-[3-[4-[3-[[amino-(hexylcarbamoylamino)methylidene]amino]propyl]piperazin-1-yl]propyl]carbamimidoyl]-3-hexylurea;methanesulfonic acid |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.50
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (20.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||